Adverse drug events leading to admission at a community nonteaching hospital

Journal of Clinical Outcomes Management

Volumn 14, Issue 7, 2007, Pages 389-394

  Edwards, David B ^a   Heisler, Mark ^a   Guidry, James ^a   Jordan, Robert M ^a  

^a Banner Desert Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIGOXIN; FUROSEMIDE; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SEDATIVE AGENT; STEROID; UNINDEXED DRUG; WARFARIN;

ANAPHYLAXIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BRADYCARDIA; COMMUNITY HOSPITAL; DEHYDRATION; DIGESTIVE SYSTEM ULCER; DRUG CONTRAINDICATION; DRUG FATALITY; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMATEMESIS; HEMATOMA; HEMATURIA; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY DISEASE; LIVER DISEASE; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SYNCOPE; THOUGHT DISORDER; UNITED STATES; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING;

EID: 36649022447     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
2. Gandhi TK, Burstin HR, Cook ER, et al. Drug complications in outpatients. J Gen Intern Med 2000;15:149-54.
3. Hafner JW, Belknap SM, Squillante MC, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39:258-67.
4. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006;13:372-7.
5. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug related admissions to hospital. Pharmaceutical J 2003;270:583-6.
6. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
7. Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA 1974;228:713-7.
8. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;227:301-6.
9. Jha AK, Kuperman GJ, Rittenberg E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10:113-9.
10. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-14.
11. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital [published erratum appears in JAMA 1998;281:420]. JAMA 1998;280:1317-20.
12. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001;161:2458-63.
13. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5.
14. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions and hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
15. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002;50:1962-8.
16. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1536-64.
17. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000;34:1373-9.
18. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-9.
19. McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976;89:487-90.
20. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976;33:792-5.
21. Bigby J, Dunn J, Goldman L, et al. Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in primary care facility. Am J Med 1987;83:1031-6.
22. Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions cause by iatrogenic disease. Arch Intern Med 1986;146:1931-4.
23. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992;33:61-8.
24. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.
25. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-6.
26. Bates DW. Drugs and adverse drug reactions: how worried should we be [editorial]? JAMA 1998;279:1216-7.
27. Davidoff F, Batalden P. Toward stronger evidence on quality improvement. Draft publication guidelines: the beginning of a consensus project. Qual Saf Health Care 2005;14:319-25.
28. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21:541-8.
29. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000;22:161-8.
30. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospitalized patients [published erratum appears in JAMA 1992;267:1922]. JAMA 1991;266:2847-51.
31. Schneeweiss S, Gottler M, Hasford J, et al. First results from an intensified monitoring system to estimate drug related hospital admissions. Br J Clin Pharmacol 2001;52:196-200.